Healthcare provider profile · identity verified

David Stephen Snodgrass, MD

Family Practice · LOVELAND, CO · NPI 1205834983

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	553	155
Levothyroxine Sodium	Levothyroxine Sodium	388	102
Lisinopril	Lisinopril	365	109
Amlodipine Besylate	Amlodipine Besylate	281	74
Tamsulosin Hcl	Tamsulosin Hcl	234	66
Losartan Potassium	Losartan Potassium	215	66
Metoprolol Succinate	Metoprolol Succinate	191	58
Omeprazole	Omeprazole	172	43
Pantoprazole Sodium	Pantoprazole Sodium	152	41
Simvastatin	Simvastatin	141	38
Gabapentin	Gabapentin	131	46
Metformin Hcl	Metformin Hcl	120	34
Hydrochlorothiazide	Hydrochlorothiazide	118	37
Tramadol Hcl	Tramadol Hcl	110	27
Trazodone Hcl	Trazodone Hcl	107	27
Allopurinol	Allopurinol	103	27
Rosuvastatin Calcium	Rosuvastatin Calcium	101	29
Metoprolol Tartrate	Metoprolol Tartrate	97	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	29
Zolpidem Tartrate	Zolpidem Tartrate	88	18
Citalopram Hbr	Citalopram Hydrobromide	77	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	21
Albuterol Sulfate Hfa	Albuterol Sulfate	71	30
Olanzapine	Olanzapine	67	suppressed
Potassium Chloride	Potassium Chloride	65	21
Warfarin Sodium	Warfarin Sodium	65	18
Alendronate Sodium	Alendronate Sodium	63	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	32
Glimepiride	Glimepiride	61	16
Metformin Hcl Er	Metformin Hcl	61	22
Furosemide	Furosemide	60	19
Duloxetine Hcl	Duloxetine Hcl	58	17
Sertraline Hcl	Sertraline Hcl	58	14
Carvedilol	Carvedilol	57	14
Gemfibrozil	Gemfibrozil	51	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	14
Atenolol	Atenolol	49	14
Bupropion Xl	Bupropion Hcl	46	12
Baclofen	Baclofen	44	14
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	11
Meloxicam	Meloxicam	43	20
Ondansetron Odt	Ondansetron	41	suppressed
Propranolol Hcl	Propranolol Hcl	41	suppressed
Prednisone	Prednisone	40	25
Lorazepam	Lorazepam	39	15
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Montelukast Sodium	Montelukast Sodium	38	11
Celecoxib	Celecoxib	36	17
Finasteride	Finasteride	35	13
Ibandronate Sodium	Ibandronate Sodium	35	11
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Bumetanide	Bumetanide	33	12
Ezetimibe	Ezetimibe	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	11
Ozempic	Semaglutide	31	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Eliquis	Apixaban	29	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	12
Lovastatin	Lovastatin	29	suppressed
Naproxen	Naproxen	29	14
Buspirone Hcl	Buspirone Hcl	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Guanfacine Hcl	Guanfacine Hcl	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	25	suppressed
Azithromycin	Azithromycin	24	23
Valsartan	Valsartan	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Glipizide Er	Glipizide	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Alprazolam	Alprazolam	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Indomethacin	Indomethacin	18	12
Januvia	Sitagliptin Phosphate	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Cephalexin	Cephalexin	16	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Famotidine	Famotidine	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	12
Eszopiclone	Eszopiclone	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Calcitriol	Calcitriol	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Felbamate	Felbamate	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Temazepam	Temazepam	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Glipizide	Glipizide	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error